Methylmalonic acid

CAS No. 516-05-2

Methylmalonic acid ( Methylpropanedioic acid;Isosuccinic acid;Methylmalonate;NSC 25201;MMA )

Catalog No. M19615 CAS No. 516-05-2

Methylmalonate (MMA) is a dicarboxylic acid that can be derived from methylmalonyl-coenzyme A. It is an indicator of Vitamin B-12 deficiency in cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    Methylmalonic acid
  • Note
    Research use only not for human use.
  • Brief Description
    Methylmalonate (MMA) is a dicarboxylic acid that can be derived from methylmalonyl-coenzyme A. It is an indicator of Vitamin B-12 deficiency in cancer.
  • Description
    Methylmalonate (MMA) is a dicarboxylic acid that can be derived from methylmalonyl-coenzyme A. It is an indicator of Vitamin B-12 deficiency in cancer.
  • Synonyms
    Methylpropanedioic acid;Isosuccinic acid;Methylmalonate;NSC 25201;MMA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    516-05-2
  • Formula Weight
    118.09
  • Molecular Formula
    C4H6O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 25 mg/mL;Water: 100 mg/mL;Ethanol: 100 mg/mL
  • SMILES
    CC(C(O)=O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vashi P et al. Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer. PLoS One. 2016 Jan 25;11(1):e0147843.
molnova catalog
related products
  • Secretin (28-54), hu...

    Secretin (28-54), human, which acts on human secretin receptors, is a 27-amino acid residue C-terminally amidated peptide, .

  • Adipamidoxime

    Adipamidoxime is an active compound.

  • 2-Amino-6-(methylsul...

    2-Amino-6-(methylsulfonyl)benzothiazole is identified as a new development of improved pteridine reductase-1 (PTR1) inhibitors and anti-trypanosomatidic agents.